357 related articles for article (PubMed ID: 21372503)
21. Reversal of neuromuscular blockade by sugammadex does not affect EEG derived indices of depth of anesthesia.
Illman H; Antila H; Olkkola KT
J Clin Monit Comput; 2010 Oct; 24(5):371-6. PubMed ID: 20734116
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy and safety of sugammadex (Org 25969) in reversing deep neuromuscular block induced by rocuronium or vecuronium in Japanese patients].
Takeda J; Iwasaki H; Otagiri T; Katoh T; Shingu K; Obara H; Nakatsuka H; Tomiyama Y; Kasaba T
Masui; 2014 Oct; 63(10):1083-8. PubMed ID: 25693333
[TBL] [Abstract][Full Text] [Related]
23. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
[TBL] [Abstract][Full Text] [Related]
24. Rocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy: A case Report.
Kim JE; Chun HR
Medicine (Baltimore); 2017 Mar; 96(13):e6456. PubMed ID: 28353578
[TBL] [Abstract][Full Text] [Related]
25. A randomized, dose-finding, phase II study of the selective relaxant binding drug, Sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block.
Groudine SB; Soto R; Lien C; Drover D; Roberts K
Anesth Analg; 2007 Mar; 104(3):555-62. PubMed ID: 17312208
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of sugammadex for antagonistic neuromuscular block in patients with radical resection of lung cancer under thoracoscope].
Ba YF; Liu YN; He SH; Li HM; Wang HR; Zhu JP; Xing WQ; Li CS
Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(3):213-219. PubMed ID: 32008289
[No Abstract] [Full Text] [Related]
27. The use of rocuronium in a patient with cystic fibrosis and end-stage lung disease made safe by sugammadex reversal.
Porter MV; Paleologos MS
Anaesth Intensive Care; 2011 Mar; 39(2):299-302. PubMed ID: 21485682
[TBL] [Abstract][Full Text] [Related]
28. Reversal of neuromuscular blockade with sugammadex in a patient with spinal muscular atrophy type III (Kugelberg-Welander syndrome).
Vilela H; Santos J; Colaço J; Oliveira E; Canas-da-Silva P
J Anesth; 2012 Apr; 26(2):306-7. PubMed ID: 22198219
[No Abstract] [Full Text] [Related]
29. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M
Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
[TBL] [Abstract][Full Text] [Related]
30. Reversal of moderate and intense neuromuscular block induced by rocuronium with low doses of sugammadex for intraoperative facial nerve monitoring.
Fabregat López J; Porta Vila G; Martin-Flores M
Rev Esp Anestesiol Reanim; 2013 Oct; 60(8):465-8. PubMed ID: 23664256
[TBL] [Abstract][Full Text] [Related]
31. Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study.
Cammu G; de Kam PJ; De Graeve K; van den Heuvel M; Suy K; Morias K; Foubert L; Grobara P; Peeters P
Br J Anaesth; 2010 Oct; 105(4):487-92. PubMed ID: 20630888
[TBL] [Abstract][Full Text] [Related]
32. [Case of anesthesia for thoracoscopic thymectomy in a pediatric patient with myasthenia gravis: reversal of rocuronium-induced neuromuscular blockade with sugammadex].
Takeda A; Kawamura M; Hamaya I; Kitamura H; Muto R; Mitono H
Masui; 2012 Aug; 61(8):855-8. PubMed ID: 22991811
[TBL] [Abstract][Full Text] [Related]
33. Sugammadex: a cyclodextrin to reverse neuromuscular blockade in anaesthesia.
Donati F
Expert Opin Pharmacother; 2008 Jun; 9(8):1375-86. PubMed ID: 18473711
[TBL] [Abstract][Full Text] [Related]
34. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
[TBL] [Abstract][Full Text] [Related]
35. Sugammadex-rocuronium dosing.
Kopman AF
Anesth Analg; 2007 Sep; 105(3):883-4; author reply 884. PubMed ID: 17717263
[No Abstract] [Full Text] [Related]
36. Retrospective analysis of spontaneous recovery from neuromuscular blockade produced by empirical use of rocuronium.
Yamamoto H; Uchida T; Yamamoto Y; Ito Y; Makita K
J Anesth; 2011 Dec; 25(6):845-9. PubMed ID: 21935686
[TBL] [Abstract][Full Text] [Related]
37. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery.
Rahe-Meyer N; Berger C; Wittmann M; Solomon C; Abels EA; Rietbergen H; Reuter DA
Anaesthesist; 2015 Jul; 64(7):506-12. PubMed ID: 26126940
[TBL] [Abstract][Full Text] [Related]
38. Recovery of laryngeal nerve function with sugammadex after rocuronium-induced profound neuromuscular block.
Pavoni V; Gianesello L; Martinelli C; Horton A; Nella A; Gori G; Simonelli M; De Scisciolo G
J Clin Anesth; 2016 Sep; 33():14-9. PubMed ID: 27555126
[TBL] [Abstract][Full Text] [Related]
39. [Reversal of rocuronium induced neuromuscular block with sugammadex in a patient with myasthenia gravis].
Nakamori E; Nitahara K; Sugi Y; Katori K; Matsuzaki A; Higa K
Masui; 2013 Aug; 62(8):972-4. PubMed ID: 23984578
[TBL] [Abstract][Full Text] [Related]
40. Electromyographic activity of the diaphragm during neostigmine or sugammadex-enhanced recovery after neuromuscular blockade with rocuronium: a randomised controlled study in healthy volunteers.
Schepens T; Cammu G; Saldien V; De Neve N; Jorens PG; Foubert L; Vercauteren M
Eur J Anaesthesiol; 2015 Jan; 32(1):49-57. PubMed ID: 25111539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
